Maximizing Cell Yields Using Perfusion

Progress in cell and gene therapy research will accelerate clinical cell therapy programs in the coming years. As cell therapy trials advance from pre-clinical to late-stage trials, cell culture platforms will need to meet increasing demands for cell yield. In this webinar, Dr. Ann Rossi Bilodeau: •Shares data supporting efficient expansion of HEK293T and Vero cells •Demonstrates how the Corning® CellCube® system provides a simple, compact, and scalable method for mass culture of attachment-dependent cells •Shows you can achieve yields of greater than 10 billion cells with efficient medium usage 00:00 - 01:30: Introduction 1:31 - 7:50: Considerations and challenges for scaling adherent cell growth 7:51 - 14:07: Corning® CellCube® Culture System 14:08 - 24:30: Case Study - HEK293T and Vero Cell Expansion 24:31 - 34:30: Q&A Session About the Presenter: Dr. Ann Rossi Bilodeau graduated from the University of Rochester School of Medicine and Dentistry with a Ph.D. in Pharmacology and received postdoctoral training at the University of Chicago. Ann began her career with Corning Life Sciences as the Applications Lab Manager where she utilized her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, Dr. Rossi Bilodeau is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube and HYPERStack platforms.